COMMUNIQUÉS West-GlobeNewswire

-
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
26/03/2024 -
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26/03/2024 -
Hapbee Announces Closing of Private Placement
26/03/2024 -
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
26/03/2024 -
Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and Solutions
26/03/2024 -
Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI
26/03/2024 -
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
26/03/2024 -
Les scientifiques de l’hôpital spécialisé et centre de recherche King Faisal contribuent aux efforts internationaux de lutte contre l’antibiorésistance des bactéries en identifiant une toute nouvelle espèce de bactérie : Riyadhensis
26/03/2024 -
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
26/03/2024 -
Save the date for ALK’s Capital Markets Day on 4 June 2024
26/03/2024 -
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
26/03/2024 -
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
26/03/2024 -
American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO
26/03/2024 -
Forbes Recognizes Luna as a Top-Rated Employer in its List of America’s Best Employers for 2024
26/03/2024 -
Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
26/03/2024 -
PharmAla Biotech Signs Sale Agreement with Numinus
26/03/2024 -
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
26/03/2024 -
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
26/03/2024 -
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
26/03/2024
Pages